Pivotal Bio Venture Partners Investment Advisor LLC Recursion Pharmaceuticals, Inc. Transaction History
Pivotal Bio Venture Partners Investment Advisor LLC
- $109 Million
- Q4 2024
A detailed history of Pivotal Bio Venture Partners Investment Advisor LLC transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Pivotal Bio Venture Partners Investment Advisor LLC holds 595,518 shares of RXRX stock, worth $5.06 Million. This represents 3.7% of its overall portfolio holdings.
Number of Shares
595,518Holding current value
$5.06 Million% of portfolio
3.7%Shares
1 transactions
Others Institutions Holding RXRX
# of Institutions
331Shares Held
276MCall Options Held
2.53MPut Options Held
2.68M-
Vanguard Group Inc Valley Forge, PA34MShares$289 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl32.3MShares$275 Million1.91% of portfolio
-
Baillie Gifford & CO24.9MShares$211 Million0.13% of portfolio
-
Black Rock Inc. New York, NY17.3MShares$147 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA15.4MShares$131 Million1.41% of portfolio
About RECURSION PHARMACEUTICALS, INC.
- Ticker RXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 180,480,000
- Market Cap $1.53B
- Description
- Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...